Rare diseases

Study first to show efficacy of a biologic for primary Sjögren’s syndrome

Researchers have for the first time shown efficacy of a single biologic in patients with primary Sjögren’s syndrome, paving the way for future studies and raising hopes for the first disease-modifying treatment for the condition. A research team led by rheumatologists at University Hospitals Birmingham NHS Foundation undertook a Phase 2b dose-finding study of the ...

Already a member?

Login to keep reading.

© 2022 the limbic